Makker Gotham 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Mar 25, 2024
Insider Transaction Report
Form 4
Makker Gotham
Director
Transactions
- Sale
Common Stock
2024-03-21$28.43/sh−274,000$7,790,943→ 365,912 total(indirect: By Simran Investment Group)
Footnotes (1)
- [F1]The securities may be deemed beneficially owned by Gotham Makker, M.D., who serves as the Chief Executive Officer and Chief Investment Officer of Simran Investment Group and who is a director of the Issuer. Dr. Makker exercises voting and dispositive control over the securities held by Simran Investment Group and is therefore deemed be the beneficial owner of securities owned or controlled by Simran Investment Group. Notwithstanding the foregoing, Dr. Makker disclaims personal beneficial ownership of the reported securities held by Simran Investment Group, except to the extent of his pecuniary interest therein.